Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
AS-605240
Cat. No.:
OB0225LY-0493
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
AS-605240 is a selective inhibitor that primarily targets the PI3Kδ pathway.
Synonym:
AS 605240; 648450-29-7; (5Z)-5-(Quinoxalin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione; (Z)-5-(Quinoxalin-6-ylmethylene)thiazolidine-2,4-dione; (5Z)-5-(6-Quinoxalinylmethylene)-2,4-thiazolidinedione; 5-[(Quinoxalin-6-yl)methylidene]-1,3-thiazolidine-2,4-dione
CAS No.:
648450-29-7
Compound CID:
5289247
Formula:
C12H7N3O2S
Formula Weight:
257.27
Specification
Relative Density:
1.553 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
AS-605240 can be used to study diseases related to the immune system or play an important role in preventing infections and allergic reactions.
Library Information
Targets:
PI3K
Receptors:
PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ
Pathways:
PI3K/Akt/mTOR signaling; Autophagy
Plate Number:
AOCL-7
Plate Location:
d3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
1 mg/mL
